Barbora Neprašová Selected Research

Prolactin-Releasing Hormone (Prolactin Releasing Hormone)

1/2022	Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances.
1/2021	Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models.
1/2019	Metabolomic Study of Obesity and Its Treatment with Palmitoylated Prolactin-Releasing Peptide Analog in Spontaneously Hypertensive and Normotensive Rats.
1/2018	Prolactin-releasing peptide improved leptin hypothalamic signaling in obese mice.
1/2018	Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbora Neprašová Research Topics

Disease

6	Obesity 01/2022 - 01/2018
5	Body Weight (Weight, Body) 01/2022 - 01/2018
3	Insulin Resistance 01/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2021
2	Glucose Intolerance 01/2022 - 01/2021
1	Hypertension (High Blood Pressure) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Prediabetic State (Prediabetes) 01/2020
1	Hypercholesterolemia 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Tauopathies 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Decapitation 01/2018
1	Amyloid Plaque 01/2018

Drug/Important Bio-Agent (IBA)

5	Prolactin-Releasing Hormone (Prolactin Releasing Hormone)IBA 01/2022 - 01/2018
5	palm11-PrRP31IBA 01/2022 - 01/2018
4	LeptinIBA 01/2022 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2021 - 01/2018
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2021 - 01/2018
1	Insulin (Novolin)FDA Link 01/2022
1	LipidsIBA 03/2021
1	NeuropeptidesIBA 01/2021
1	FructoseIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	tau Proteins (tau Protein)IBA 01/2018
1	Liraglutide FDA Link 01/2018
1	AntibodiesIBA 01/2018

Therapy/Procedure

1	Therapeutics 01/2021